Three-year clinical outcomes from ABSORB China


As we try to understand emerging BRS devices, we turn to China’s pioneer in interventional cardiology, R-L Gao, who introduces the latest clinical results of ongoing trials pitting BRS against XIENCE. We look at the historical progression of definite or probable stent thrombosis and tease out how these results compare to national and regional trials taking place throughout the world. Looking at the increasingly positive results, we explore the role that patient selection or vessel size play.